🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Kemp Dolliver

Stock Analyst at Brookline Capital Markets

(0.90)
# 4,082
Out of 5,162 analysts
64
Total ratings
33.3%
Success rate
-2.8%
Average return

Stocks Rated by Kemp Dolliver

Lantheus Holdings
Jul 28, 2026
Downgraded: Hold
Price Target: $100 → $105
Current: $102.10
Upside: +2.84%
Lisata Therapeutics
Jul 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.91
Upside: -
Perimeter Medical Imaging AI, Inc.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $1.54
Current: $0.14
Upside: +1,040.74%
Cellectar Biosciences
Jul 12, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $0.8829
Upside: +1,598.95%
IceCure Medical
Jun 17, 2026
Reiterated: Buy
Price Target: $83 → $74
Current: $0.9971
Upside: +7,271.38%
Rein Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3677
Upside: -
Verrica Pharmaceuticals
Dec 17, 2025
Upgraded: Buy
Price Target: $17
Current: $2.89
Upside: +489.25%
Monopar Therapeutics
Sep 25, 2025
Reiterated: Buy
Price Target: $52 → $93
Current: $70.29
Upside: n/a
iBio, Inc.
Sep 5, 2025
Reiterated: Buy
Price Target: $1.6
Current: $0.801
Upside: n/a
Bioceres Crop Solutions
Aug 22, 2025
Downgraded: Hold
Price Target: $24 → $26
Current: $0.1829
Upside: n/a
Reiterated: Buy
Price Target: $36 → $11
Current: $0.452
Upside: n/a
Initiated Coverage: Buy
Price Target: $18
Current: $0.673
Upside: n/a
Initiated Coverage: Buy
Price Target: $25
Current: $5.13
Upside: n/a
Initiated Coverage: Buy
Price Target: $11
Current: $0.784
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $2.34
Upside: n/a
Upgraded: Buy
Price Target: $31
Current: $0.401
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.6109
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.101
Upside: n/a
Upgraded: Buy
Price Target: $25 → $30
Current: $2.28
Upside: n/a
Downgraded: Hold
Price Target: $7 → $4.5
Current: $0.0126
Upside: n/a
Initiated Coverage: Buy
Price Target: $19 → $23
Current: $4.85
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Reiterated: Buy
Price Target: $13
Current: $2.18
Upside: n/a
Initiated Coverage: Buy
Price Target: $8
Current: $2.61
Upside: n/a